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ABSTRACT 
Hypertension is a medical condition that is well-established 
as a risk factor for many major diseases. For example, it can 
cause alterations in the cardiac structure and function over 
time that can lead to heart related morbidity and mortality. 
However, at the subclinical stage, these changes are subtle 
and cannot be easily captured using conventional cardiovas- 
cular indices calculated from clinical cardiac imaging. In this 
paper, we describe a radiomics approach for identifying in- 
termediate imaging phenotypes associated with hypertension. 
The method combines feature selection and machine learn- 
ing techniques to identify the most subtle as well as com- 
plex structural and tissue changes in hypertensive subgroups 
as compared to healthy individuals. Validation based on a 
sample of asymptomatic hearts that include both hypertensive 
and non-hypertensive cases demonstrate that the proposed ra- 
diomics model is capable of detecting intensity and textural 
changes well beyond the capabilities of conventional imaging 
phenotypes, indicating its potential for improved understand- 
ing of the longitudinal effects of hypertension on cardiovas- 
cular health and disease. 
Index Terms— Hypertension, cardiovascular disease, ra- 
diomics, UK Biobank, machine learning. 
 
1. INTRODUCTION 
to identify the subtle changes induced by hypertension at the 
subclinical stage. Furthermore, there is a major knowledge 
gap as to which perturbations take place in the heart over time 
in hypertensive patients and which lead to full-blown cardio- 
vascular remodeling and dysfunctions. 
In this paper, we propose a radiomics approach for deeper 
imaging phenotyping of cardiovascular alterations occurring 
in hypertensive patients with healthy hearts. To the best of our 
knowledge, this is the first radiomics based method and study 
dedicated to the quantification of subtle cardiac changes at the 
subclinical stage in asymptomatic individuals. The radiomics 
concept has been developed and exploited mostly in oncology 
with promising results for tumor classification and treatment 
planning [4, 5], while their usage in other clinical domains 
such as cardiology is only recent [6, 7]. In this paper, we an- 
alyze a large pool of advanced imaging features describing a 
range of shape, size, intensity and textural properties of the 
cardiac structures and tissues. By combining feature selec- 
tion and supervised classification techniques, the goal is to 
identify a set of radiomic features that best discriminate be- 
tween the normal and hypertensive cases in healthy hearts, 
well beyond the capabilities of conventional clinical indices 
such as ejection fraction. The proposed radiomics model is 
trained and validated on newly acquired datasets from the UK 
Biobank. 
 
Hypertension is a major risk factor for cardiovascular diseases 
and events [1]. Approximately 77% of people who have a first 
stroke and 70% of people who have a first heart attack have 
hypertension [2]. This condition,  while not directly linked  
to the heart, can induce longtidudinal alterations in the heart 
over a long period well before symptoms of cardiovascular 
disease develop. Eventually, this can lead to major cardiac 
diseases such as heart failure and left ventricular hypertrophy 
[3]. It is therefore of paramount importance to identify indi- 
viduals at risk of developping hypertension-related diseases at 
early stage to apply preventive and corrective measures. How- 
ever, existing cardiovascular imaging indices are not suitable 
2. MATERIALS AND METHODS 
 
2.1. Data description and segmentations 
The UK Biobank is a large-scale population health resource 
(500,000 individuals) aimed at enhancing biomedical re- 
search like never before, ultimately improving prevention, 
diagnosis and treatment of a wide range of serious and life 
threatening illnesses such as heart disease. The UK Biobank 
holds an exceptional amount of data which includes biomed- 
ical data, physical measures, accelerometry, multimodal 
imaging including abdominal, brain and cardiac magnetic 
resonance imaging (MRI) scans as well as whole body DXA 
imaging, genome-wide genotyping and longitudinal follow- 
up for a wide range of health-related outcomes [8]. For this 
paper, 200 cardiac cine-MRI images were randomly selected, 
including 100 hypertensive patients and 100 cases without 
hypertension. Both subgroups have no evidence of cardio- 
vascular disease. The cardiac images were acquired with 1.5 
Tesla scan (MAGNETOM Area, Syngo Platform VD13A, 
Siemens Healthcare, Erlangen, Germany) and have an in- 
plane resolution of 1.8x1.8 mm
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, a slice thickness of 8.0 mm 
and a slice gap of 2 mm. Manual annotation of the images 
was undertaken by our clinical collaborator (S.E. Pe- tersen), 
resulting in a segmentation of the left ventricle (LV), 
myocardium (MYO) and right ventricle (RV) boundaries [9]. 
 
2.2. Radiomics feature calculation 
The goal of this work is to analyze a sufficiently large and di- 
verse radiomics features such that relevant cardiac alterations 
due to hypertension can be captured. Concretely, we calculate 
a total of 686 radiomic features describing a range of shape, 
size, intensity or textural characteristics of the cardiac sub- 
structures and tissues (LV, MYO, RV). These include: 
Shape features will  capture  geometrical  alterations  
in the cardiac structures, while size features will 
measure global and localized remodelling or dilata- 
tion/hypertrophy due to disease. The main shape/size 
radiomics include sphericity, compactness, elongation, 
ratios, diameters and main axes. In this paper, these 
estimated shape/size radiomics will be used to identify 
morphological remodeling occurring in hypertensive 
but not in non-hypertensive individuals. 
First-order intensity statistics will inform on the distri- 
bution of the gray level values in the cardiac tissues, 
without focusing on their spatial relationships. These 
include simple measures such as the mean intensity in a 
particular region of the tissue or the standard deviation, 
as well as more advanced measures such as skewness, 
uniformity or entropy. 
Advanced textural features will measure changes in 
the spatial relationships, local contrasts and tissue 
homogeneity within the different cardiac structures. 
These radiomic features can be beneficial, for exam- 
ple, to capture potential alterations in the trabeculae, 
papillary muscles and fibrosis in hypertensive vs. non- 
hypertensive subgroups. Different texture methods are 
included: Gray Level Co-occurrence Matrix (GLCM), 
Gray Level Run Length Matrix (GLRLM), Neigh- 
boring Gray Tone Difference Matrix (NGTDM) and 
Fractal Dimension (FD). 
 
2.3. Radiomic feature selection 
Our hypothesis in this work is that the most subtle changes in 
cardiac morphology, tissue or local texture due to hyperten- 
sion, even in initial asymptomatic stages, will be captured by 
some of the multi-type radiomics, thus leading to new imag- 
ing phenotypes that could be used for early diagnosis of hy- 
pertension related subclinical heart disease. We expect that 
not all of the radiomics markers will be relevant for this anal- 
ysis. Instead, a radiomic feature selection is necessary to se- 
lect those features that specifically deviate from normality in 
the presence of hypertension. 
In this work, we do this by combining sequential forward 
feature selection (SFFS) [10] with radiomics-based classifica- 
tion to identify the most relevant radiomics features as those 
that best classify hypertensive vs. non-hypertensive hearts in 
an SVM model. 
Within a cross-validation scheme, the SFFS technique 
will enable to select sequentially, one at a time, the radiomic 
features that improve the overall classification of hyperten- 
sive vs. non-hypertensive individuals. The very first radiomic 
feature to be selected with this procedure is the one that best 
separate hypertensive and normal cases among all radiomic 
features. Sequentially, new radiomic features are added to 
provide complementary evidence for the classification and 
description of the hypertensive imaging phenotypes. 
In this method, SVM is chosen as the underlying classi- 
fication model due its well-known performance when classi- 
fying image data, in particular in the case of small sample 
size. An SVM model corresponds to a separation of the ex- 
amples by the hyperplanes that have the largest distance to the 
nearest training-data point of any class (so-called functional 
margin). This ensures that the examples belonging to the dif- 
ferent classes, in our cases hypertensive vs. normal hearts are 
separated as clearly as possible. 
At the end of the procedure, radiomic features that have 
similar or overlapping distributions between the classes of 
interest are ignored, while those that contribute to the SVM 
classification of hypertensive and normal hearts are included 
within the final set of optimal radiomic features, indicating 
their relevance for describing hypertension related changes in 
asymptomatic hearts. 
 
3. RESULTS 
In this study, 10-fold cross validation tests are performed to 
select the optimal radiomic feature that best separate hyper- 
tensive and non-hypertensive hearts. Note that after appli- 
cation of the proposed feature selection method, the classi- 
fication accuracy, measured as the number of correct classi- 
fication divided by the number of cases, reaches 0.8. This 
confirms the hypothesis that hypertension does indeed alters 
the values of radiomics features even at the subclinical stage. 
This is further illustrated in Figure 1, which shows that us- 
ing conventional imaging phenotypes of cardiovascular func- 
tion, (i.e. ejection fractions, stroke volumes and volumes of 
left and right ventricles at end-diastolic and end-systolic time 
frames) results in a low classification of the normal and hy- 
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pertension subgroups, with an area under curve (AUC) score 
of 0.62  0.09.  This is an expected result as the hyperten-  
sive individuals are asymptomatic with normal cardiovascular 
structure and functions as evaluated by the clinicians. Instead, 
the proposed radiomics model significantly improves classifi- 
cation with AUC score of 0.76 0.13. 
After demonstrating the relevance of the radiomics approach 
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Fig. 1. ROC curves using the proposed method with se- 
lected radiomics features (top) and conventional imaging phe- 
notypes (bottom). 
 
for discriminating the hypertension and normal subgroups, 
Table 1 lists the selected radiomics features, which sum to 11 
features. It can be seen that all selected features are intensity 
and texture radiomics, which indicate that the main changes 
due to hypertension are in the actual tissues rather than the 
geometry and size of the ventricles or myocardium. This also 
explains the inability of conventional indices to characterize 
changes due to hypertension as these typically focus on the 
quantification of cardiac structure and function only. It is im- 
portant to note that the selected radiomic features cover both 
end-diastole and end-systole (second column), as well as all 
three cardiac substructures (LV, MYO, RV - third column). 
Furthermore, The fourth column of the table lists the classifi- 
cation scores when using each feature alone, showing they do 
not separate well between the two subgroups, with the accu- 
racy varying between 0.415 (Inverse difference moment nor- 
Table 1. List of 11 radiomics features selected by the pro- 
posed method for discriminating the hearts of hypertensive 
and normal individuals. Alone: Classification accuracy using 
only this feature. W/O: Accuracy when removing the feature. 
ED: end-diastolic. ES: end-systolic. 
 
Name Frame Structure Alone W/O 
Homogeneity 1 ES LV 0.495 0.77 
Inverse variance ES LV 0.55 0.685 
Inverse difference moment normalized ED MYO 0.415 0.74 
Sum of squares ED MYO 0.485 0.765 
Large area emphasis ED LV 0.455 0.785 
Zone entropy ED LV 0.56 0.725 
Large area low gray level emphasis ED RV 0.485 0.765 
Short run emphasis ES RV 0.505 0.79 
Long run emphasis ED MYO 0.555 0.795 
Coarseness ED MYO 0.62 0.76 
Gray level non-uniformity ES MYO 0.635 0.71 
 
malized) and 0.635 (Gray level non-uniformity). This con- 
firms that the hypertension related changes are indeed small 
and subtle. It is the combination of all the features into a ra- 
diomic signature, describing multiple co-occurring changes in 
the heart, that is best suited for optimal classification reaching 
a score of 0.8. 
 
Normal ED Normal ES 
 
Hypertensive ED Hypertensive ES 
 
Fig. 2. Images of hypertensive and normal cases with the 
same LVEF values and different radiomics signature. 
 
Finally, to further illustrate the benefit of the radiomics 
approach, Figure 2 shows a comparison between two hearts 
corresponding to normal (above) and hypertensive (bottom) 
cases, respectively. Both hearts look visually normal and fur- 
thermore they have the same left ventricular ejection fraction 
(LVEF) value (60%), indicating normal cardiac functions in 
both cases. In contrast, as shown in Table 2, the proposed 
Table 2. Original and normalized radiomics values for the two cases of Figure 2. 
 
 Original Normalized 
 Normal Hypertensive Normal Hypertensive 
Homogeneity 1 0.543 0.546 -0.199 -0.133 
Inverse variance 0.395 0.390 0.838 0.644 
Inverse difference moment normalized 0.981 0.992 -1.3880 1.386 
Sum of squares 0.706 0.936 -0.467 0.161 
Large area emphasis 196 6910 -1.315 0.151 
Zone entropy 5.79 5.62 0.910 0.089 
Large area low gray level emphasis 5 100 -0.885 -0.532 
Short run emphasis 0.913 0.831 2.217 -0.325 
Long run emphasis 1.76 2.80 -1.692 -0.401 
Coarseness 0.00968 0.00203 7.761 -1.090 
Gray level non-uniformity 298 1670 -2.192 1.427 
 
radiomic signature enables to show clear differences between 
the two cases in the radiomic space. Several of the normalized 
radiomic values (using z-normalization) indicate differences 
between the values in the normal and hypertensive cases, such 
as for the large area emphasis (-1.31 vs. 0.15), short run em- 
phasis (-2.21 vs. 0.32) and gray level non-uniformity (-2.19 
vs. 1.42). The obtained results show the existence of textu- 
ral differences between hypertensive and normal subgroups 
that cannot be captured by using clinical conventional indices 
such as EF or using visual examination. 
 
4. DISCUSSION AND CONCLUSIONS 
To the best of our knowledge, this is the first  radiomics 
study performed to identify subclinical changes and quan- 
tify intermediate phenotypes associated with hypertension in 
otherwise healthy hearts. The results indicate that the main 
changes are in the cardiac textures and tissues, which explains 
the inability of conventional imaging indices, which focus on 
structural and functional quantification, to identify these al- 
terations. This paper shows the promise of the proposed 
radiomics approach for analyzing subtle and more complex 
effects of non-cardiac risk factors of heart disease such as 
hypertension. Future work includes clinical interpretation of 
the results (e.g. fibrosis formation), as well as application to 
other risk factors such as diabetes and cholesterol effects. 
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